error
Divisa

CORONAVIRUS DISEASE 2019 (COVID-19)

EPIDEMIOLOGY, PATHOGENESIS, DIAGNOSIS, AND THERAPEUTICS

9789811548130 ::  CORONAVIRUS DISEASE 2019 (COVID-19)
ISBN:

9789811548130

Col·lecció:MEDICAL VIROLOGY: FROM PATHOGENESIS TO DISEASE CONTROL
EditorialSPRINGER NATURE
Edició:
Pàgines:213
Idioma:INGLES
Oferta per estudiants
P.V.P.: 149,99 € + 4% IVA = 155,99 €
Dto 5% Estalvies 7,80 €
Import final iva incl. 148,19 €
Entrega en 15 dies

CHAPTER 1_GLOBAL TRENDS IN EPIDEMIOLOGY OF CORONAVIRUS DISEASE 2019 (COVID-19). -CHAPTER 1.1. INTRODUCTION. -CHAPTER 1.2. 21ST CENTURY SARS-COV-2 OUTBREAKS, EPIDEMICS. -CHAPTER 1.3.WORLDWIDE SURVEILLANCE SYSTEMS. -CHAPTER 1.4. REGIONS OF POTENTIAL THREAT. -CHAPTER 1.5. PANDEMIC SARS-COV-2. -CHAPTER 1.6. CONCLUSIONS. -CHAPTER 1.7. FUTURE PERSPECTIVES. -CHAPTER 1.8. REFERENCES. -CHAPTER 2_GENOME ORGANIZATION AND PATHOGENESIS OF NOVEL CORONAVIRUS 2019 (SARS-COV-2). -CHAPTER 2.1. INTRODUCTION. -CHAPTER 2.2. STRUCTURE AND GENOME OF SARS-COV-2. -CHAPTER 2.3. REPLICATION AND LIFE CYCLE OF VIRUS. -CHAPTER 2.3.1 ATTACHMENT. -CHAPTER 2.3.2.ENTRY. -CHAPTER 2.3.3. RECEPTORS. -CHAPTER 2.3.4. UNCOATING. -CHAPTER 2.3.5. SYNTHESIS OF VIRAL RNA. -CHAPTER 2.3.6. VIRAL PROTEINS . -CHAPTER 2.3.7. EGRESS. -CHAPTER 2.4. CONCLUSIONS. -CHAPTER 2.5. FUTURE PERSPECTIVES. -CHAPTER 3_HOST IMMUNE RESPONSE AGAINST HUMAN SARS-COV-2 INFECTION. -CHAPTER 3.1. INTRODUCTION. -CHAPTER 3.2. IMMUNE RESPONSE. -CHAPTER 3.3. HUMORAL IMMUNE RESPONSE. -CHAPTER 3.4.CELLULAR IMMUNE RESPONSE. -CHAPTER 3.5. CONCLUSIONS. -CHAPTER 3.6. FUTURE PERSPECTIVES. -CHAPTER 4_EMERGENCE AND RE-EMERGENCE OF SARS CORONAVIRUSES. -CHAPTER 4.1. INTRODUCTION. -CHAPTER 4.2. SARS-COV TO SARS-COV-2: RNA RECOMBINATION, ANTIGENIC SHIFT AND ANTIGENIC DRIFT. -CHAPTER 4.3. CONCLUSIONS. -CHAPTER 4.4. FUTURE PERSPECTIVES. -CHAPTER 5_TRANSMISSION CYCLE OF SARS-COV AND SARS-COV-2. . -CHAPTER 5.1. INTRODUCTION. -CHAPTER 5.2. CORONAVIRUS TRANSMISSION CYCLE. -CHAPTER 5.2.1. TRANSMISSION AMONG ANIMALS. -CHAPTER 5.2.2. TRANSMISSION IN ANIMALS TO HUMAN. -CHAPTER 5.2.3.TRANSMISSION AMONG HUMANS. -CHAPTER 5.2.4. OTHER HOSTS. -CHAPTER 5.3. CONCLUSIONS. -CHAPTER 5.4. FUTURE PERSPECTIVES. -CHAPTER 6_PREPARING FOR THE PERPETUAL CHALLENGES OF PANDEMICS OF CORONAVIRUS INFECTIONS WITH SPECIAL FOCUS ON SARS-COV-2. -CHAPTER 6.1. INTRODUCTION. -CHAPTER 6.2. STRATEGIES FOR PANDEMIC PREPAREDNESS FOR CORONAVIRUS. -CHAPTER 6.2.1. UPDATED SURVEILLANCE SYSTEM. -CHAPTER 6.2.2. STRATEGIES FOR IMPLEMENTATION OF LABORATORY DIAGNOSTIC SERVICES DURING PANDEMICS. -CHAPTER 6.2.3. MANAGEMENT OF BULK VACCINES, ANTIVIRAL DRUGS. -CHAPTER 6.3. PROMOTING FACILITIES FOR TREATMENT AND HOSPITALISATION, HEALTHCARE PERSONNEL, MAINTENANCE OF HYGIENE AND DISINFECTION DURING PANDEMICS. -CHAPTER 6.3.1.GLOBAL MANAGEMENT STRATEGIES OF CORONAVIRUS INFECTION. -CHAPTER 6.3.2.ECONOMIC CONSEQUENCES OF PANDEMIC RISK. -CHAPTER 6.3.3.CONCLUSIONS. -CHAPTER 6.3.4. FUTURE PERSPECTIVES. -CHAPTER 7. CLINICAL MANIFESTATIONS AND DIAGNOSIS OF HUMAN SARS-COV-2 INFECTION. . -CHAPTER 7.1. INTRODUCTION. -CHAPTER 7.2. GENERAL SYMPTOMS OF SARS-COV-2 INFECTION. -CHAPTER 7.3. CLINICAL COURSE. -CHAPTER 7.4. CLINICAL COMPLICATIONS. -CHAPTER 7.5. DIAGNOSIS OF SARS-COV-2. -CHAPTER 7.6. CONCLUSIONS. -CHAPTER 7.7. FUTURE PERSPECTIVES. -CHAPTER 8. TREATMENT AND DRUGS FOR SARS-COV-2. . -CHAPTER 8.1. INTRODUCTION. -CHAPTER 8.2. ANTIVIRAL DRUGS FOR SARS-COV-2. -CHAPTER 8.3. CURRENT AVAILABLE DRUGS, PHARMACOKINETICS, TOXICITY, EFFICACY, RESISTANCE, DRUG INTERACTIONS, RECOMMENDATIONS FOR USE. . -CHAPTER 8.4. COMPLEMENTARY AND ALTERNATIVE MEDICINES FOR SARS-COV-2. . -CHAPTER 8.5. CONCLUSIONS. -CHAPTER 8.6. FUTURE PERSPECTIVES. -CHAPTER 9. PREVENTION AND CONTROL STRATEGIES FOR SARS-COV-2 INFECTION. . -CHAPTER 9.1. INTRODUCTION. -CHAPTER 9.2. SARS-COV-2 VACCINE DEVELOPMENT. -CHAPTER 9.3. TYPES OF CORONAVIRUS VACCINES. -CHAPTER 9.4. EFFICACY AND EFFECTIVENESS OF CORONAVIRUS VACCINES. -CHAPTER 9.5. CONTROL STRATEGIES OF CORONAVIRUS INFECTION. -CHAPTER 9.6. CONCLUSIONS

THIS BOOK PROVIDES A COMPREHENSIVE OVERVIEW OF RECENT NOVEL CORONAVIRUS (SARS-COV-2) INFECTION, THEIR BIOLOGY AND ASSOCIATED CHALLENGES FOR THEIR TREATMENT AND PREVENTION OF NOVEL CORONAVIRUS DISEASE 2019 (COVID-19). DISCUSSING VARIOUS ASPECTS OF COVID-19 INFECTION, INCLUDING GLOBAL EPIDEMIOLOGY, GENOME ORGANIZATION, IMMUNOPATHOGENESIS, TRANSMISSION CYCLE, DIAGNOSIS, TREATMENT, PREVENTION, AND CONTROL STRATEGIES, IT HIGHLIGHTS HOST-PATHOGEN INTERACTIONS, HOST IMMUNE RESPONSE, AND PATHOGEN IMMUNE INVASION STRATEGIES TOWARD DEVELOPING AN IMMUNE INTERVENTION OR PREVENTIVE VACCINE FOR COVID-19.AN UNDERSTANDING OF THE TOPICS COVERED IN THE BOOK IS IMPERATIVE IN THE CONTEXT OF DESIGNING STRATEGIES TO PROTECT THE HUMAN RACE FROM FURTHER LOSSES AND HARM DUE TO SARS-COV-2 INFECTION CAUSING COVID-19.

BIOLOGIA
GENETICA
IMMUNOLOGIA
MEDICINA TROPICAL
MICROBIOLOGIA
Llibres relacionats
ISBN: 9781071606155 CRISPR-CAS METHODSCRISPR-CAS METHODS
9781071606155
Junio 2020

149.99€ S/I
142,49€ S/I

ISBN: 9780128184448 WHEAT AND BARLEY GRAIN BIOFORTIFICATIONWHEAT AND BARLEY GRAIN BIOFORTIFICATION
9780128184448
Mayo 2020

Oferta per estudiants

143€ S/I
135,85€ S/I

ISBN: 9780128234143 BENEFICIAL MICROBES IN AGRO-ECOLOGYBENEFICIAL MICROBES IN AGRO-ECOLOGY
9780128234143
Mayo 2020

Oferta per estudiants

350€ S/I
332,50€ S/I

ISBN: 9780198813286 GENETICS AND THE LITERARY IMAGINATIONGENETICS AND THE LITERARY IMAGINATION
9780198813286
Mayo 2020

59.82€ S/I
56,83€ S/I

ISBN: 9780198813347 GENETICS AND THE LITERARY IMAGINATIONGENETICS AND THE LITERARY IMAGINATION
9780198813347
Mayo 2020

22,72€ S/I